High Points and Hurdles: Cancer Immunotherapy Moves Forward | Immunology and Biotherapies | Scoop.it
Immunotherapy is maintaining its momentum in clinical development programs, with explorations under way in many tumor types, including breast and lung cancers previously considered poor candidates for such modalities.

Via Dr. Stefan Gruenwald